1021703

Nitrofurantoin Related Compound A

United States Pharmacopeia (USP) Reference Standard

• Sinónimos: 3-(5-Nitrofurfurylideneamino)hydantoic acid, N-(Aminocarbonyl)-N-{[(5-nitro-2-furanyl)methylene]amino}glycine
• Fórmula empírica (notación de Hill): C₈H₈N₄O₆
• Número CAS: 63981-22-6
• Peso molecular: 256.17
• MDL number: MFCD00514237
• UNSPSC Code: 41116107
• NACRES: NA.24

Propiedades

• grade: pharmaceutical primary standard
• agency: USP
• API family: nitrofurantoin
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: [N+](=O)([O-])c1[o]c(cc1)\C=N\N(CC(=O)O)C(=O)N, O=C(O)CN(N=CC=1OC(=CC1)N(=O)=O)C(=O)N
• InChI: 1S/C8H8N4O6/c9-8(15)11(4-7(13)14)10-3-5-1-2-6(18-5)12(16)17/h1-3H,4H2,(H2,9,15)(H,13,14)/b10-3+
• InChI key: URYZARAFMQWNPZ-XCVCLJGOSA-N

Descripción

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Nitrofurantoin Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Nitrofurantoin Oral Suspension

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Información de seguridad

• pictograms: GHS07
• signalword: Warning
• hcodes: H302
• pcodes: P301 + P312 + P330
• Hazard Classifications: Acute Tox. 4 Oral
• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable